Your Catalyst to a Lucrative Business
Breast Cancer Market Share, Size,Growth, Key Players, Outlook
and Forecasts to 2025 | Hexa Research
“ The global breast cancer market is anticipated to witness a significant
growth over the forecast period.”
31 December 2018
The global breast cancer market is anticipated to witness a significant growth over the forecast period on
account of growing target population base across the globe, rising prevalence of the disease, unhealthy
lifestyle, exposure to radiations, and lack of physical exercises. Moreover, increasing efforts taken by major
organizations across various regions to increase awareness levels is estimated to drive the market. Rising
investments in R&D by various government and private organizations for development of effective drugs and
treatments is also projected to play a key role in the market growth.
For instance, CytoDyn Inc., a biotech firm developing humanized CCR5 monoclonal antibodies for several
therapeutic indications, received FDA approval for its Investigation New Drug (IND) submission and is allowed
to start a phase 1b/2 trial for metastatic Triple-Negative Breast Cancer (TNBC). This disease subtype is one of
the leading causes of cancer deaths across the globe and it accounts for around 10 % of the overall cases. The
firm has identified several trial sites and aims to dose a few patients and expects to have initial readout
during the first quarter of 2019. Changes in the number of Circulating Tumor Cells (CTCs) will be assessed
every 21 days throughout the trial.
Breast cancer is detected during a screening test or after the patient notices a lump, which is the most
common physical sign. According to the World Health organization (WHO), every year, about 200,000 new
cases of breast cancer are diagnosed globally and this number is likely to increase in future. Some of the
Follow Us: